You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PNAS this week: droplet-based mRNA sequencing strategy, secretome mouse model, and more.
Geisinger researchers will work with collaborators at the nonprofit FH Foundation to develop new methods for the identification and cascade testing of FH.
A team led by researchers at the NHLBI are testing the efficacy of measuring ddcfDNA in blood as a biomarker of chronic rejection for lung transplants.
Nucleosome organization appears to follow two principles, according to the researchers' analyses of three different cell types.
Participants in the pilot will begin developing the capabilities required for the planned data commons, including making data transparent and interoperable.
The funding will support research projects using data from the Trans Omics for Precision Medicine program to uncover disease pathology.
Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body.
The partners are developing an assay to detect minimal residual disease in leukemia patients, for use with Sellas' investigational AML drug.
Funded projects will support the agency's Trans Omics for Precision Medicine program, which is focused on heart, lung, blood, and sleep disorders.
The CCHMC will act as the coordinating center for members of the NHLBI's Cardiovascular Development Consortium and Pediatric Cardiac Genomics Consortium.
Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.
According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.
In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.
Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.